tert-Butyl (3-(3-aminophenyl)propyl)carbamate, 95+%, 1g

6-Hydroxy-2-[6-[N-(tert-butoxycarbonyl)-N-methylamino]pyridin-3-yl]quinoline, 98%, 500mg

Lithium sulphate monohydrate, min. 99%, pa, 250 g, plastic packaging.

Gallium(II) telluride, 99%, 25g

(R)-tert-Butyl 3-(hydroxymethyl)-3,4-dihydroisoquinoline-2(1H)-carboxylate, 95%, 250mg

DBD-H [=4-(N,N-Dimethylaminosulfonyl)-7-hydrazino-2,1,3-benzoxadiazole] [for HPLC Labeling]>98.0%(HPLC)100mg

2-Amino-3-methoxybenzoic Acid>99.0%(HPLC)(T)5g

Silver(I) iodide, 97.0%, 1g

6-Chloroquinolin-3-amine, 95.0%, 100mg

2-Cyclobutoxypyridin-3-amine, 97%, 250mg

4-[1-(methylamino)ethyl]benzene-1-sulfonamide, 95%, 1g

5-(2-Bromo-4-(trifluoromethoxy)phenyl)oxazole, 98%, 250mg

5-Hydroxy-4-methylfuran-2(5H)-one, 95.0%, 100g